The PET facility at the Austin Hospital consists of a medical cyclotron with dedicated radiochemistry facilities and two whole body PET Scanners.

  • Cyclotron

    In the 1980's, short-lived radionuclides were available only in the large physics research centres with access to particle accelerators or nuclear reactors. The increasing clinical applications of cyclotron produced radioisotopes have led to the rapid rise in the number of compact cyclotrons throughout the world. All medical cyclotrons currently available are suitable for sustaining a major program for PET research and clinical application. Cyclotrons have been established worldwide, with eight cyclotron facilities in operation in Australia: three in Melbourne, two in Sydney, one in Perth and two in Brisbane.

    Cyclone 10/5 at IBA Factory (Belgium).


    Specifications of the Austin Health cyclotron production facility:

    Cyclotron: IBA Cyclone 10/5
    Installation Date: 1992
    Beam: 50mA 10MeV proton
    30mA 5MeV deuteron
    Targetry: Five targets (2 x 18F, 11C,13N & 15O)
    Hotcell: Ten lead-shielded hotcells
    Radiochemistry: Five radiochemistry for 18F nucleophilic substitution; two for 11C-methylation, one for 15O-water production and one for radioactive gas delivery.
    Clean Room: One clean room facility for sterile production of 18FDG
    Radiopharmacy: Standard equipment for quality control (Radio-HPLC, Radio-TLC, GC, GC-MS)


  • Cyclotron Operation

    The cyclotron in operation at the Austin Hospital is a Cyclone 10/5 from IBA (Louvain-la-Neuve, Belgium). This negative ion design machine accelerates H- ion to 10 MeV and D- ion to 5 MeV. At the extraction radius, the negative particles are stripped of their electrons by passing through a very thin carbon foil and the resulting positively charged ions (H+ or D+) are bent outwards to the target ports, by the magnetic field. Up to 50 mA of proton and 30 mA of deuteron beam intensity can be extracted onto a single target or divided between two oppositely mounted targets. The cylindrical magnet return yoke consisting of 15 cm of steel acts as the primary radiation shield and in addition the machine is enclosed inside a cylindrical shielding system consisting of 68 cm thickness of boron-doped water. Experimental measurements indicate that the cyclotron shielding, together with the 60 cm thick concrete wall of the vault, is sufficient to keep the radiation dose level outside the cyclotron vault to a safe level. In public areas, measurements of neutron and gamma dose rates were 0.007 µSv/h and 0.24 µSv/h respectively.
    Staff checking the central region inside the machine.


  • Targetry

    Currently our machine is fitted with 4 targets remotely loaded or unloaded by gas pressures. Two types of target are used: liquid target for 18F production with 1mL titanium insert; and gas target for 11C and 15O production with a 20 mL aluminium insert. These gas targets can be run in either continuous flow or bolus mode at a loading pressure of up to 11 bar. The radioisotopes produced are automatically transported via narrow bore tubing from the targets to the chemistry modules in the hotcells laboratory.


  • Radiochemistry modules

    Radiolabelling of compounds involves considerable amounts of radioactivity and must be performed by remote control in lead-shielded hotcells. Two types of hotcells have been installed within the laboratory: two large hotcells with viewing area mainly used for research and development; and eight small shielded hotcells used to house automated radiochemistry modules for routine radiopharmaceutical production. Manufacture and installation of the lead-shielded hotcells were performed by Bucek Industries (Geelong, Australia).

    18F-radiolabelling is performed in fully automated synthesis modules. Five modules are currently in operation including two from IBA (Ion Beam Applications, Belgium), one from EBCO Technologies (Richmond, BC, Canada), one from Coincidence SA (Belgium) and one from GE (GE Medical Systems).

    11C-radiolabelling is performed in two in-house built system, with one based on remote controlled electrovalves that are manually activated by the operator and the other one based on a fully computerised system.

    15O-radiolabelling is performed using in-house chemistry modules located in the scanner room.
    Small hotcells with hinge doors.
    Large hotcells with front sliding doors.


  • Radiation Monitoring

    Staff monitoring the Programable Logic Controller. Radiation detectors are installed in all work area and are monitored and logged by a dedicated computer system. The cyclotron vault is monitored for both neuron and gamma radiation and the radiochemistry lab and scanner for gamma only. Operation of the Cyclotron, targets and chemistry modules is carried out automatically by computers to minimise exposure to workers.


  • PET Scanner

    PET is principally different from SPECT by virtue of it ability to determine the line-of-response of a photon by "electronic" rather than "physical" collimation.

    Commercial PET scanners operate in either "so-called" two- or three-dimensional acquisition modes. In two-dimensional mode, lead septa are positioned between the rings of detectors to shield against cross-ring coincidences. By retracting the septa, the sensitivity of the scanner can be increased significantly, however, this results in an increase in the scatter and randoms rate.

    The Austin Hospital in Melbourne operated a Siemens/CTI 951 (Knoxville, TN, USA) from 1992 to 2003. The ECAT-951/31R consisted of 16 rings of BGO detectors (Bi4Ge3O12), an axial range of 10.8 cm and a ring aperture of 56.7 cm diameter. It featured a retractable septa so that it could be operated in 2- or 3-D mode. The scanner was used principally in 2-D mode for clinical studies and 3-D mode for research studies.

    PET Scanner - Side view. PET Scanner - Front view.


    Specifications:

    PET Scanner: Siemens/CTI 951
    Number of Detector rings: 16
    Number of crystals: 8192 BGO
    Crystal dimensions: 6.25 (Transaxial) x 6.75 (Axial) x 30 (Radial) mm3
    Detector Ring diameter: 1020 mm
    Patient portal diameter: 567 mm
    Axial FOV: 108 mm
    Number of Image Planes: 31
    Plane Spacing: 3.375 mm
    Resolution (18FDG):
        Transaxial off-axis 0cm 5.8 mm
      10 cm 6.4 mm
      20 cm 7.7 mm
      Axial off-axis 0 cm 5.0 mm
      10 cm 5.7 mm
      20 cm 7.1 mm
    Sensitivity (2D, 250 keV LLD): 110 kcps/mCi/cc, 2970 cps/kBq/cc
    Transmission source: 3 rotating Ge-68 rods @ 0.5 mCi/rod



    In July 2002, the Austin Hospital Centre for PET commissioned a Philips Allegro PET scanner. The following year in September 2003, the Centre further commissioned a Philips Gemini PET/CT scanner. These Allegro/Gemini PET cameras are fully 3-D and comprise of 29 rings of GSO (Gd2SiO5) detectors with an axial extent of 180 mm and a patient aperture of 565 mm.

    Gemini PET Scanner


    Specifications:

    PET Scanner: Philips Allegro/Gemini
    Number of Detector rings: 29
    Number of crystals: 17864 GSO
    Number of PMT's: 420
    Crystal dimensions: 4 (Transaxial) x 6 (Axial) x 20 (Radial) mm3
    Detector Ring diameter: 800 mm
    Patient portal diameter: 565 mm
    Axial FOV: 180 mm
    Number of Image Planes: 90 or 45
    Plane Spacing: 2 or 4 mm
    Resolution (18FDG):
        Transaxial off-axis 0cm 4.73 mm
      10 cm 5.59 mm
      Axial off-axis 0 cm 4.74 mm
      10 cm 5.89 mm
    NEMA-1994 Sensitivity : 19.7 kcps/kBq/mL
    NEMA-1994 Scatter fraction : 32%
    NEMA-2001 Sensitivity : 4.6 cps/kBq
    NEMA-2001 Scatter fraction : 39%
    Transmission source: Rotating 740 MBq 137Cs point source
    Reconstruction Algorithms: FORE3D+ FBP
      FORE3D + OSEM, AW-OSEM
      FORE3D + RAMLA2D
      RAMLA3D


  • Data Processing

    Clinician interpreting results from the PET Scanner. Emission and transmission data are acquired by the PET scanner hardware and stored on the acquisition computer sub-system. Coincidence events are stored in acquisition memory in either histogram or listmode format.

    In histogram mode, events are incrementally binned whilst in listmode, the binning stage is performed off-line. The binning stage converts the event from the coincident detector pairs to a Line Of Response to give an angle and offset of the event.

    This so-called ‘sinogram’ representation of the data corresponds to sets of 2-dimensional projections of the tracer distribution. Whole body scans are performed by acquiring multiple ‘beds’ where the patient is scanned sequentially by moving the bed to cover the region of interest.

    After emission and transmission acquisition for each bed are acquired, the data are reconstructed using dedicated high performance hardware. The transmission data are used to generate attenuation correction data to be applied to the emission data.

    The reconstruction of the attenuation corrected emission data gives a volume where each voxel represents the concentration of radio-isotope at that location in the volume. A range of algorithms are used from analytic methods such as FBP (Filtered Back Projection) to Iterative methods such as OSEM (Ordered Subsets Expectation Maximisation) and RAMLA (Row Action Maximum Likelihood Algorithm).

    Using bio-mathematical models, the PET data can be further transformed into information with physiological, pathological or pharmacological significance. In addition, a full determination of the quantitative information available from the image requires a kinetic model of the transport mechanism and of the physiological and biochemical processes in which each radiopharmaceutical participates.





Facilities/Equipment    |    Basic Principle of PET
PET Radionuclides & Radiopharmaceuticals
Radiopharmacy    |    PET Nuclear Physics & Tomography
PET Principles of Tracer Modelling    |    Clinical Applications